00000nam 2200000za 4500 9.833902 CaOODSP 20221107150321 cr ||||||||||| 170320s2017 onc #ob f000 0 eng d 978-0-660-08004-8 CaOODSP eng n-cn--- HP40-157/2017E-PDF Updated recommendations on human papillomavirus (HPV) vaccines [electronic resource] : 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule. At head of title: Advisory committee statement (ACS) - National Advisory Committee on Immunization (NACI) 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule [Ottawa] : Public Health Agency of Canada, 2017. 55 p. Issued also in HTML format. Issued also in French under title: Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) : vaccin nonavalent contre le VPH et précisions sur les intervalles minimums entre les doses dans le calendrier d'immunisation contre le VPH. Includes bibliographical references. "In February 2015, a nine-valent human papillomavirus vaccine (HPV9) (Gardasil®9, Merck Canada, Inc.) was authorized for use in Canada. The purpose of this statement is to summarize information on this vaccine and to provide evidence-based recommendations on its use in the context of recommendations for all HPV vaccines currently authorized for use in Canada. In addition, this statement will clarify minimum intervals between doses of HPV vaccines for two-dose and three-dose HPV immunization schedules"--Introduction, p. 7. gccst Sexually transmitted diseases gccst Immunization Canada. National Advisory Committee on Immunization. Public Health Agency of Canada. Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) (CaOODSP)9.833903 Updated recommendations on human papillomavirus (HPV) vaccines (CaOODSP)9.818011 PDF 1.18 MB https://publications.gc.ca/collections/collection_2017/aspc-phac/HP40-157-2017-eng.pdf HTML N/A https://www.canada.ca/en/public-health/services/publications/healthy-living/9-valent-hpv-vaccine-clarification-minimum-intervals-between-doses-in-hpv-immunization-schedule.html Pub.: 160384